SciClone Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 39   

Articles published

SCLN 6.86 +0.23 (3.47%)
price chart
SciClone Pharma, BTG Say China's FDA Approves DC Bead
SciClone Pharmaceuticals, Inc. (SCLN: Quote), and its partner BTG plc (BTG.L), Thursday said the China Food and Drug Administration has approved the registration of DC Bead for the embolization of malignant hypervascularized tumors.
SciClone and BTG Announce That DC Bead(R) Has Been Approved by China ...  MarketWatch
Related articles »  
SciClone Pharmaceuticals Inc. (SCLN) Jumps 8.83% on August 25
SciClone Pharmaceuticals Inc. (SCLN) was among the biggest gainers on the Russell 2000 for August 25 as the stock popped 8.83% to $6.90, representing a gain of $0.56 per share.
Related articles »  
SciClone Pharmaceuticals Inc. (SCLN) Issues FY14 Earnings Guidance
SciClone Pharmaceuticals logo SciClone Pharmaceuticals Inc. (NASDAQ:SCLN) issued an update on its FY14 earnings guidance on Monday morning.
SciClone Pharmaceuticals (SCLN) Posts Quarterly Earnings, Beats Estimates By ...  WKRB News
Related articles »  
SciClone Pharmaceuticals Inc.: SciClone Pharmaceuticals to Report Financial ...
FOSTER CITY, CA -- (Marketwired) -- 07/31/14 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report financial results for the second quarter 2014 on Monday, August 11, 2014.
SciClone Pharmaceuticals to Report Financial Results for the Second Quarter ...  CNNMoney
Related articles »  
SciClone Pharmaceuticals Reaches New 52-Week High at $6.70 (SCLN)
SciClone Pharmaceuticals (NASDAQ:SCLN) last released its earnings data on Monday, August 11th. The company reported $0.20 earnings per share for the quarter, beating the analysts' consensus estimate of $0.10 by $0.10.
Stocks to Keep Your Eyes on: SciClone Pharmaceuticals, Inc. (SCLN), OraSure ...
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) augmented +8.83% to close at $6.90 in the last trading session and its total traded volume was 852,981 shares versus average volume of 274,367.
SciClone Pharmaceuticals (SCLN) to Release Earnings on Monday
The company had revenue of $26.60 million for the quarter, compared to the consensus estimate of $32.20 million. During the same quarter last year, the company posted $0.08 earnings per share. SciClone Pharmaceuticals's revenue was down 10.7% ...
Insider Buying: SciClone Pharmaceuticals Director Purchases 25040 Shares of ...
SciClone Pharmaceuticals logo SciClone Pharmaceuticals (NASDAQ:SCLN) Director Nancy T. Chang purchased 25,040 shares of the company's stock on the open market in a transaction that occurred on Friday, August 15th. The shares were purchased at ...
SciClone Pharmaceuticals Director Nancy T. Chang Acquires 25040 Shares ...  Watch List News (press release)
Insider Buying: SciClone Pharmaceuticals Director Buys 25040 Shares of Stock ...  sleekmoney
Related articles »  
Stocks to Watch : Yum! Brands (NYSE:YUM), SciClone Pharmaceuticals ...
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) announced that it plans to report financial results for the second quarter 2014 on Monday, August 11, 2014.
Related articles »  
SciClone Pharmaceuticals' (SCLN) CEO Friedhelm Blobel on Q2 2014 Results ...
Good day, ladies and gentlemen, and welcome to the Second Quarter 2014 SciClone Pharmaceuticals Inc. Financial Results Conference Call.
SciClone Reports Financial Results for the Second Quarter 2014  Marketwired (press release)
Related articles »